Cargando…
Treatment of Drug Susceptible Pulmonary Tuberculosis
Tuberculosis (TB) remains a major global health problem, and the incidence of TB cases has not significantly decreased over the past decade in Korea. The standard short course regimen is highly effective against TB, but requires multiple TB-specific drugs and a long treatment duration. Recent studie...
Autores principales: | Shin, Hong-Joon, Kwon, Yong-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499581/ https://www.ncbi.nlm.nih.gov/pubmed/26175767 http://dx.doi.org/10.4046/trd.2015.78.3.161 |
Ejemplares similares
-
Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
por: Jeon, Doosoo, et al.
Publicado: (2020) -
The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test Results
por: Joh, Joon-Sung, et al.
Publicado: (2007) -
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis
por: Kwon, Yong-Soo
Publicado: (2017) -
Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis
por: Kim, Hyung-Jun, et al.
Publicado: (2023) -
Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis
por: Lee, Hyun, et al.
Publicado: (2020)